Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis

British Journal of Rheumatology

Volumn 35, Issue 1, 1996, Pages 24-32

  Dolhain, R J E M ^a   Ter Haar, N T ^a   Hoefakker, S ^b   Tak, P P ^a   De Ley, M ^c   Claassen, E ^b   Breedveld, F C ^a   Miltenburg, A M M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TNO   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Interferon gamma; Interferon gamma receptor; Osteoarthritis; Rheumatoid arthritis; T lymphocytes

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERFERON RECEPTOR;

ARTICLE; CHRONIC TONSILLITIS; CLINICAL ARTICLE; DELAYED HYPERSENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN; SYNOVIUM; T LYMPHOCYTE;

EID: 0029921352     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.1.24     Document Type: Article

References (57)

1. Zehen van D, Hazes JMW, Zwinderman AH et al. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:822-30.
2. Haraoui B, Pelletier JP, Cloutier JM, Faure MF, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1991;34:153-63.
3. Potocnik AJ, Kinne E, Menninger H, Zacher J, Emmrich F, Kroczek RA. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 1990;31:213-24.
4. Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 1982;79: 3632-6.
5. Paulus HE, Machleder HI, Levine S, Yu DTY, MacDonald NS. Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. Arthritis Rheum 1977;20:1249-62.
6. Kotzin BL, Strober S, Engleman EG et al. Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 1981;305:969-76.
7. Trentharn DE, Belli JA, Andersen RJ et al. Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med 1981;305:976-82.
8. Rijthoven AWAM, Dijkmans BAC, Goei The HS et al. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. Ann Rheum Dis 1986;45:726-31.
9. Chen E, Keystone EC, Fish EN. Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993; 36:901-10.
10. Firestein GS, Alvaro-Garcia JM, Maki R. Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
11. Warren CJ, Howell WM, Bhambhani M, Cawley MID, Smith JL. An investigation of T-cell subset phenotype and function in the rheumatoid synovium using in situ hybridization for IL-2 mRNA. Immunology 1991;72: 250-5.
12. Waalen K, Sioud M, Natvig JB, Førre Ø. Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes. Scand J Immunol 1991;36:865-73.
13. Simon AK, Seipelt E, Sieper J. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci USA 1994:91:8652-6.
14. Buchan G, Barrett K, Fujita T, Taniguchi T, Maini R, Feldmann M. Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL-2), IL-2 receptor and IFNγ. Clin Exp Immunol 1988; 71:295-301.
15. Hopkins SJ, Meager A. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988;73:88-92.
16. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA. Synovial fluid concentrations of five dilferent cytokines in rheumatic diseases. Ann Rheum Dis 1990;49:676-81.
17. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. Arthritis Rheum 1987;30:864-71.
18. Yanni G, Whelan A, Feighery C et al. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol 1993;93:387-95.
19. Husby G, Williams RC. Immunohistochemical studies of interleukin-2 and gamma-interferon in rheumatoid arthritis. Arthritis Rheum 1985;28:174-81.
20. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990;33: 768-73.
21. Miltenburg AMM, van Laar JM, de Kuiper R, Daha MR, Breedveld FC. T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset. Scand J Immunol 1992;35:603-10.
22. Andersson U, Sander B, Andersson J, Möller G. Concomitant production of different lymphokines in activated T cells. Eur J Immunol 1988;18:2081-4.
23. Bucy RP, Panoskaltsis-Mortari A, Huang GQ et al. Heterogeneity of single cell cytokine gene expression in clonal T cell populations. J Exp Med 1994;180:1251-62.
24. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Altman R, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
26. Parker RH, Pearson CM. A simplified synovial biopsy needle. Arthritis Rheum 1963;6:172-6.
27. Ritchie DM, Boyle JA, McInnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
28. Heijde vd DMFM, van't Hof MA, van Riel PLCM et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
29. Meide van der PH, Dubbeld M, Schellekens H. Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods 1985;79:293-305.
30. Depla E, De Ley M. Monoclonal antibodies against the human interferon-gamma receptor(s). Mol Immunol 1990;27:745-50.
31. Hoefakker S, van't Erve EHM, Deen C et al. Immunohistochemical detection of co-localizing cytokine and antibody producing cells in the extrafollicular area of human palatine tonsils. Clin Exp Immunol 1993;93:223-8.
32. Volpes R, van den Oord J, De Vos R, Delpa E, De Ley M, Desmet VJ. Expression of interferon-gamma receptor in normal and pathological human liver tissue. J Hepatol 1991;12:195-202.
33. Tak PP, Kummer JA, Hack CE et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 1994;12:1735-43.
34. Bishop GA, Matsumoto Y, McCaughan GW, Kenney JS. Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1β, IL-6, IFN-gamma and basic fibroblast growth factor. Transplant Proc 1992;24:2310-2.
35. Res PCM, Struijk L, Leow A, Daha MR, van den Elsen PC, Breedveld FC. Inflamed joints of patients with rheumatoid arthritis contain T cells that display in vitro proliferation to antigens present in autologous synovial fluid. Functional analysis on the basis of synovial-fluid-reactive T-cell clones and lines. Human Immunol 1994; 40:291-8.
36. Chu CQ, Field M, Andrew E, Haskard D, Feldmann M, Maini RN. Detection of cytokines at the site of tuberculin-induced delayed-type hypersensitivity in man. Clin Exp Immunol 1992;90:522-9.
37. Kalish RS, Johnson KL. Enrichment and function of urushiol (poison ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol. J Immunol 1990;145:3706-13.
38. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
39. Lafyatis R, Thompson NI, Remmers EF et al. Transforming growth factor-β production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritis rats. J Immunol 1989;143:1142-8.
40. Lotz M, Kekow J, Carson DA. Transforming growth factor-β and cellular immune responses in synovial fluids. J Immunol 1990;144:4189-94.
41. Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148:1143-8.
42. Stoll G, Müller S, Schmidt B et al. Localization of interferon-gamtna and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis. Am J Pathol 1993;142:1866-75.
43. Haufelder AE, Bahn RS. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23:10-17.
44. Paulesu L, Bocci V, King A, Loke YM. Immunocytochemical localization of interferons in human trophoblast populations. J Biol Regul Homeost Agents 1991;5:81-5.
45. Hashimoto K, Kagetsu N, Yoshiki Y. Immunohistochemistry and electron microscopy in Langerhans cell histiocytosis confined to the skin. J Am Acad Dermatol 1991;25:1044-53.
46. Neumann C, Schaumburg-Lever G, Döpfer R, Kolde G. Interferon gamma is a marker for histiocytosis X cells in the skin. J Invest Dermatol 1988;91:280-2.
47. Umehara F, Izumo S, Ronquillo AT, Matsumoro K, Sato E, Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol 1994;53:72-7.
48. Keifer R, Kreutzberg GW. Gamma interferon-like immunoreactivity in the rat nervous system. Neuroscience 1990;37:725-34.
49. Lortat-Jacobs H, Kleinman UK, Grimaud JA. High-affinity binding of interferon-gamma to a basement membrane complex (Matrigel). J Clin Invest 1991;87:878-83.
50. Valente G, Ozmen L, Novelli F et al. Distribution of interferon-gamma receptor in human tissues. Eur J Immunol 1992;22:2403-12.
51. Wight, TN. Cell biology of arterial proteoglycans. Arteriosclerosis 1989;9:1-20.
52. Langris M, Daireaux M, Jouis V, Bocquet J, Loyau G. Interleukin-1-like factor (mononuclear cell factor) modulates proteoglycan synthesis in cultured human synovial cells. Biochim Biophys Acta 1987;927:34-42.
53. Neumann C, Sorg C. Immune Interferon. I. Production by lymphokine-activated murine macrophages. Eur J Immunol 1977;7:719-25.
54. Eneroth A, Andersson T, Olsson T, Örvell C, Norrby E, Kristensson K. Interferon-gamma-like immunoreactivity in sensory neurons may influence the replication of sendai and mumps viruses. J Neurosci Res 1992;31:487-93.
55. Robinson BWS, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invent 1985;75:1488-95.
56. Wiranowska-Stewart M, Stewart II WE. Determination of human leucocyte populations involved in production of interferons alpha and gamma. J Interferon Res 1981; 1:233-44.
57. Klein NA, Pérgola GM, Rao-Tekmal R, Dey TD, Schenken RS. Enhanced expression of resident leukocyte interferon-gamma mRNA in endometriosis. Am J Reprod Immunol 1993; 30:74-81.